Ropivacaine Injection Manufacturer in India

Cyproheptadine 2mg/5ml syrup is a first-generation antihistamine with unique antiserotonergic activity that stimulates appetite. It is widely used as an appetite stimulant for children with poor growth and undernutrition — a high-prevalence condition in Sub-Saharan Africa and South Asia. It is also used for allergic conditions, urticaria and migraine prophylaxis. 9M India manufactures Cyproheptadine syrup at scale for export to these high-demand markets.

Yes. 9M India manufactures Promethazine Hydrochloride 5mg/5ml syrup — a first-generation antihistamine with antiemetic, sedative and anticholinergic properties. Promethazine is widely used for allergic conditions, motion sickness, nausea and vomiting, pre-anaesthetic medication and as a sedative. It is a WHO Essential Medicine and one of the highest-volume antihistamine syrups in export markets.

Yes. 9M India manufactures antiepileptic oral liquid formulations including Phenobarbitone Syrup 20mg/5ml and Levetiracetam Oral Solution 100mg/ml for paediatric epilepsy management. These are essential medicines for children who cannot swallow tablets — a consistent institutional demand item in hospital paediatric neurology departments and government epilepsy programmes globally.

First-generation antihistamines (Promethazine, Chlorpheniramine, Cyproheptadine) cross the blood-brain barrier — causing sedation, which is a side effect in allergy treatment but a therapeutic benefit in nausea, pre-anaesthesia and sleep. Second-generation antihistamines (Cetirizine, Levocetirizine) do not significantly cross the blood-brain barrier — providing anti-allergic benefit without sedation. Both generations are in active export demand and 9M India manufactures syrup formulations across both classes.

Yes. Sugar-free antihistamine syrup formulations — using Sorbitol, Sucralose or Saccharin as sweeteners — are available for Cetirizine, Cyproheptadine and Chlorpheniramine. Sugar-free formulations are preferred for diabetic patients and in paediatric populations where sugar-containing syrups may contribute to dental caries. Please specify sugar-free requirement when placing an enquiry.

Documentation available includes WHO-GMP Certificate, DCGI Manufacturing Licence, Certificate of Pharmaceutical Product (CoPP), batch-wise Certificate of Analysis, ICH Zone IVb stability data and CTD/ACTD dossiers on request. For antiepileptic oral liquids classified as controlled or scheduled substances in certain markets, our regulatory team can advise on the appropriate export permit and documentation requirements.

Antihistamine syrup demand is highest in the Middle East, North Africa and South Asia — where allergic rhinitis and urticaria prevalence is elevated due to high dust and pollen burden, dry climatic conditions and increasing pollution levels. These are 9M India's primary Phase 1 export markets. Cyproheptadine appetite stimulant syrup shows particularly high demand in Sub-Saharan Africa where paediatric nutritional programmes drive significant volume.